Key result
Endothelin-1 elicited significantly greater increases in coronary perfusion resistance in hypertensive rat hearts compared to normotensive hearts, mediated by both ETA and ETB receptors.
Why the study?
Does endothelin-1 stimulation alter coronary perfusion resistance differently in hypertensive versus normotensive rat hearts, and what is the role of ETA and ETB receptors?
Does endothelin-1 stimulation alter coronary perfusion resistance differently in hypertensive versus normotensive rat hearts, and what is the role of ETA and ETB receptors?
The augmented vasoconstrictor response of coronary arteries to ET-1 in hypertensive hearts is mediated by both ETA and ETB receptors, potentially contributing to impaired coronary circulation in hypertension.
Answers are grounded in this paper and cite their sources.
Augmented ET-1 coronary vasoconstriction in SHR leaves open whether ETA/ETB blockade improves coronary flow in hypertension; human trials required.
To determine whether the vasoconstrictor response to endothelin-1 (ET-1) is altered in coronary vessels of hypertensive hearts and the role of ETA and ETB receptors in these responses to ET-1, the vasoconstrictor response to ET-1 in coronary vessels was measured with or without ETA and ETB receptor antagonists. In isolated hearts of spontaneously hypertensive rat (SHR) and normotensive Wistar-Kyoto (WKY) rat, the coronary perfusion pressure was measured on a Langendorff apparatus with constant pressure (75 mm Hg). Coronary perfusion resistance (CPR) (mm Hg/ml/min/g) was calculated. ET-1 elicited dose-dependent increases of CPR in both normotensive and SHR rat hearts. However, the responses were significantly greater in SHR than those of WKY. Pretreatment with the ETA antagonist FR139317 and the ETB antagonist BQ788 inhibited CPR increases with ET-1 infusion. However, vasoconstrictor responses to ET-1 were still greater in SHR than in WKY after FR139317 or BQ788 infusion. These findings suggest that the augmented vasoconstrictor response of coronary artery to ET-1 is mediated by both ETA and ETB receptors. These changes may contribute to the impaired coronary circulation in hypertension.
No takes yet. Share an insight, caveat, or question.
Miki et al. (1998) studied Hypertension. Endothelin-1 (ET-1) with or without ETA (FR139317) and ETB (BQ788) receptor antagonists vs. Normotensive Wistar-Kyoto (WKY) rat hearts was evaluated on Coronary perfusion resistance (CPR). Endothelin-1 elicited significantly greater increases in coronary perfusion resistance in hypertensive rat hearts compared to normotensive hearts, mediated by both ETA and ETB receptors.
Synapse has enriched 10 related papers. Consider them for comparative context: